Oncology (Williston Park, N.Y.)

Keyphrases

Publications

volume 38, number 1, 2024

Smita K Rao, L Johnetta Blakely, Kate Small, Stephen Schleicher, null Natalie R Dickson Md
Building Efficiency and Scaling With a Remote Genetic Counseling Program. Oncology (Williston Park, N.Y.) 38 (1) (2024)
Smita K Rao, L Johnetta Blakely, Kate Small, Stephen Schleicher, null Natalie R Dickson Md
Building Efficiency and Scaling With a Remote Genetic Counseling Program. Oncology (Williston Park, N.Y.) 38 (1) (2024)
Sonia La Spina, Paolo Scollo, Basilio Pecorino, Valentina Lombardo, Annamaria Motta, Rosa Gioia Calderone, Stefania Calì, Helga Lipari, Giuseppa Scandurra
Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in Italy. Oncology (Williston Park, N.Y.) 38 (1) (2024)
Sonia La Spina, Paolo Scollo, Basilio Pecorino, Valentina Lombardo, Annamaria Motta, Rosa Gioia Calderone, Stefania Calì, Helga Lipari, Giuseppa Scandurra
Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in Italy. Oncology (Williston Park, N.Y.) 38 (1) (2024)

volume 38, number 2, 2024

Lymphoma Research Foundation Lymphoma Research Foundation
Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma. Oncology (Williston Park, N.Y.) 38 (2) (2024)

volume 38, number 3, 2024

Michał Kostrzanowski, Grzegorz Ziółkowski, Filip Dąbrowski
Extreme Case of Surgical Port Metastasis in Ovarian Cancer. Oncology (Williston Park, N.Y.) 38 (3) (2024)
null Nora Janjan Md Mpsa Mba, Patrick J Silva
Rising Prices and Lower Medicare Reimbursement Rates Create Outrage Among Clinicians. Oncology (Williston Park, N.Y.) 38 (3) (2024)
Michał Kostrzanowski, Grzegorz Ziółkowski, Filip Dąbrowski
Extreme Case of Surgical Port Metastasis in Ovarian Cancer. Oncology (Williston Park, N.Y.) 38 (3) (2024)
Fiza Khan, Foorquan Hashmi, Nerses Ghahramanyan, Elen Baloyan, Gevorg Tamamyan, Marina Konopleva, Naveen Pemmaraju, Astghik Voskanyan
Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting. Oncology (Williston Park, N.Y.) 38 (3) (2024)
null Nora Janjan Md Mpsa Mba, Patrick J Silva
Rising Prices and Lower Medicare Reimbursement Rates Create Outrage Among Clinicians. Oncology (Williston Park, N.Y.) 38 (3) (2024)
null Nora Janjan Md Mpsa Mba, Patrick J Silva
Rising Prices and Lower Medicare Reimbursement Rates Create Outrage Among Clinicians. Oncology (Williston Park, N.Y.) 38 (3) (2024)
null Nora Janjan Md Mpsa Mba, Patrick J Silva
Rising Prices and Lower Medicare Reimbursement Rates Create Outrage Among Clinicians. Oncology (Williston Park, N.Y.) 38 (3) (2024)
Fiza Khan, Foorquan Hashmi, Nerses Ghahramanyan, Elen Baloyan, Gevorg Tamamyan, Marina Konopleva, Naveen Pemmaraju, Astghik Voskanyan
Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting. Oncology (Williston Park, N.Y.) 38 (3) (2024)

volume 38, number 4, 2024

Joanna L Langner, Frederick Millard, Vera Vavinskaya, Haiyan Zhang, Nuphat Yodkhunnatham, Aditya Bagrodia
Evaluation and Management of Testicular Cancer After Late Relapse. Oncology (Williston Park, N.Y.) 38 (4) (2024)
Joanna L Langner, Frederick Millard, Vera Vavinskaya, Haiyan Zhang, Nuphat Yodkhunnatham, Aditya Bagrodia
Evaluation and Management of Testicular Cancer After Late Relapse. Oncology (Williston Park, N.Y.) 38 (4) (2024)
Hilary R Keller, Laura Fluke, Jared A Forrester, Ronald F Wolf
Identifying Indications for Neoadjuvant Therapy in Cholangiocarcinoma. Oncology (Williston Park, N.Y.) 38 (4) (2024)
Hilary R Keller, Laura Fluke, Jared A Forrester, Ronald F Wolf
Identifying Indications for Neoadjuvant Therapy in Cholangiocarcinoma. Oncology (Williston Park, N.Y.) 38 (4) (2024)
Joanna L Langner, Frederick Millard, Vera Vavinskaya, Haiyan Zhang, Nuphat Yodkhunnatham, Aditya Bagrodia
Evaluation and Management of Testicular Cancer After Late Relapse. Oncology (Williston Park, N.Y.) 38 (4) (2024)

volume 38, number 5, 2024

null James B Yu Md Mhs Fastro, Julian C Hong
AI Use in Prostate Cancer: Potential Improvements in Treatments and Patient Care. Oncology (Williston Park, N.Y.) 38 (5) (2024)
Seth Felder, Jessica Frakes, Manju George, Allison Rosen, Ibrahim Halil Sahin
Which Treatment for Which Patient: Rectal Cancer Management After PROSPECT Trial. Oncology (Williston Park, N.Y.) 38 (5) (2024)
null James B Yu Md Mhs Fastro, Julian C Hong
AI Use in Prostate Cancer: Potential Improvements in Treatments and Patient Care. Oncology (Williston Park, N.Y.) 38 (5) (2024)
Catherine R Lewis, Jocelyn Uchic-Boccella, Jenna Zimmerman, Eirwen Miller, Sharon Liang, Patrick L Wagner
Synchronous Well-Differentiated Papillary Mesothelioma and Endometrioid Adenocarcinoma Arising From Endometriosis. Oncology (Williston Park, N.Y.) 38 (5) (2024)
Catherine R Lewis, Jocelyn Uchic-Boccella, Jenna Zimmerman, Eirwen Miller, Sharon Liang, Patrick L Wagner
Synchronous Well-Differentiated Papillary Mesothelioma and Endometrioid Adenocarcinoma Arising From Endometriosis. Oncology (Williston Park, N.Y.) 38 (5) (2024)
Seth Felder, Jessica Frakes, Manju George, Allison Rosen, Ibrahim Halil Sahin
Which Treatment for Which Patient: Rectal Cancer Management After PROSPECT Trial. Oncology (Williston Park, N.Y.) 38 (5) (2024)

volume 38, number 6, 2024

Jonathan Q Trinh, Shristi Upadhyay Banskota, Alissa S Marr
A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A Mutation. Oncology (Williston Park, N.Y.) 38 (6) (2024)
null Joshua Richter Md, Zachary M Avigan
Continued Success of Venetoclax in t(11;14) Multiple Myeloma Despite Negative Trials. Oncology (Williston Park, N.Y.) 38 (6) (2024)
Zachary M Avigan, null Joshua Richter Md
Continued Success of Venetoclax in t(11;14) Multiple Myeloma Despite Negative Trials. Oncology (Williston Park, N.Y.) 38 (6) (2024)
Zachary M Avigan, null Joshua Richter Md
Continued Success of Venetoclax in t(11;14) Multiple Myeloma Despite Negative Trials. Oncology (Williston Park, N.Y.) 38 (6) (2024)
Jonathan Q Trinh, Shristi Upadhyay Banskota, Alissa S Marr
A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A Mutation. Oncology (Williston Park, N.Y.) 38 (6) (2024)
Jonathan Q Trinh, Shristi Upadhyay Banskota, Alissa S Marr
A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A Mutation. Oncology (Williston Park, N.Y.) 38 (6) (2024)

volume 38, number 7, 2024

Georgios Evangelou, Ioannis Vamvakaris, Irene Konstantopoulou, Konstantinos Syrigos
Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs. Oncology (Williston Park, N.Y.) 38 (7) (2024)
Georgios Evangelou, Ioannis Vamvakaris, Irene Konstantopoulou, Konstantinos Syrigos
Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs. Oncology (Williston Park, N.Y.) 38 (7) (2024)

volume 38, number 8, 2024

Muhammad Hamza Gul, Aisha Rehman Siddiqui, Farwa Zehra, Malaika Rehmani, Faraz Waheed, Natasha Masood, Maleeha Saqib, Mahnoor Keen, Sharan Siddharth Keshetty, Maham Maqsood, Siddharth Arjun Atwal, Muhammad Hamza Sikandari, Abdul Baseer Wardak
Navigating a Paradigm Shift Venetoclax Treatment Redefines Landscape of Acute Myeloid Leukemia. Oncology (Williston Park, N.Y.) 38 (8) (2024)

volume 37, number 12, 2024

Sangam Shah, Rukesh Yadav, Abhinav Bhattarai, Sunraj Tharu, Prakash Sharma, Prativa Subedi, Arun Kharel, Pitambar Khanal, Pradeep Khanal Pradeep Khanal Mbbs Md, Sri Kollepara, Krishna Gundabolu
Danazol for the Treatment of Myelodysplastic Syndromes: A Systematic Review. Oncology (Williston Park, N.Y.) 37 (12) (2024)
Sangam Shah, Rukesh Yadav, Abhinav Bhattarai, Sunraj Tharu, Prakash Sharma, Prativa Subedi, Arun Kharel, Pitambar Khanal, Pradeep Khanal Pradeep Khanal Mbbs Md, Sri Kollepara, Krishna Gundabolu
Danazol for the Treatment of Myelodysplastic Syndromes: A Systematic Review. Oncology (Williston Park, N.Y.) 37 (12) (2024)

volume 37, number 4, 2023

James J Driscoll, James Ignatz-Hoover
Emerging Strategies to Manage Relapsed and/or Refractory Multiple Myeloma. Oncology (Williston Park, N.Y.) 37 (4) (2023)
Zhubin J Gahvari, Natalie S Callander
The Management of Relapsed and Refractory Multiple Myeloma. Oncology (Williston Park, N.Y.) 37 (4) (2023)
Daniel Vt Catenacci, Yoon-Koo Kang, Hope E Uronis, Keun-Wook Lee, Matthew Ch Ng, Peter C Enzinger, Se Hoon Park, Philip J Gold, Jill Lacy, Howard S Hochster, Sang Cheul Oh, Yeul Hong Kim, Kristen A Marrone, Ronan J Kelly, Rosalyn A Juergens, Jong Gwang Kim, Thierry Alcindor, Sun Jin Sym, Eun-Kee Song, Cheng Ean Chee, Yee Chao, Sunnie Kim, Do-Youn Oh, Jennifer Yen, Justin I Odegaard, Errin Lagow, Daner Li, Jichao Sun, Patrick Kaminker, Paul A Moore, Minori Koshiji Rosales, Haeseong Park
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma. Oncology (Williston Park, N.Y.) 37 (4) (2023)
James J Driscoll, James Ignatz-Hoover
Emerging Strategies to Manage Relapsed and/or Refractory Multiple Myeloma. Oncology (Williston Park, N.Y.) 37 (4) (2023)

volume 37, number 5, 2023

Arshiya Mariam, Suneel Kamath, Kimberly Schveder, Howard L McLeod, Daniel M Rotroff
Biomarkers for Response to Anti-PD-1/Anti-PD-L1 Immune Checkpoint Inhibitors: A Large Meta-Analysis. Oncology (Williston Park, N.Y.) 37 (5) (2023)
Hans Kristian Nugraha, I Gede Eka Wiratnaya, Putu Astawa
An Arthroscopic Approach for the Intralesional Curettage of Giant Cell Tumor of the Distal Femur: A Case Report. Oncology (Williston Park, N.Y.) 37 (5) (2023)
Ben Kong
The Complexities and Art of Interpreting Biomarkers and Response to Immune Checkpoint Inhibitors. Oncology (Williston Park, N.Y.) 37 (5) (2023)

volume 37, number 6, 2023

Kirollos Hanna
Erdafitinib's Road to Approval and Use in Urothelial Carcinoma. Oncology (Williston Park, N.Y.) 37 (6) (2023)
Francisco Javier Castro-Alonso, Evelyn Beas-Lozano, Yuly A Remolina-Bonilla, Thomas W Flaig, María T Bourlon
Erdafitinib in the Treatment of Metastatic Urothelial Carcinoma. Oncology (Williston Park, N.Y.) 37 (6) (2023)
Syed Arslan Shehzad Shah, Naveed Ahmed Mahar, Harris Hassan Qureshi, Muddasir Hussain, Gauhar Sultan, Rehan Mohsin, Altaf Hashmi
Squamous Cell Carcinoma of the Kidney: A Large Case Series. Oncology (Williston Park, N.Y.) 37 (6) (2023)

Oncology (Williston Park, N.Y.)

Keyphrases

Publications

volume 38, number 1, 2024

volume 38, number 2, 2024

volume 38, number 3, 2024

volume 38, number 4, 2024

volume 38, number 5, 2024

volume 38, number 6, 2024

volume 38, number 7, 2024

volume 38, number 8, 2024

volume 37, number 12, 2024

volume 37, number 4, 2023

volume 37, number 5, 2023

volume 37, number 6, 2023

volume 37, number 7, 2023

volume 37, number 8, 2023

volume 37, number 9, 2023